Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
MBLX > SEC Filings for MBLX > Form 8-K on 17-Jul-2013All Recent SEC Filings

Show all filings for METABOLIX, INC.

Form 8-K for METABOLIX, INC.


Change in Directors or Principal Officers, Regulation FD Disclosure, Financial St

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(c) and (e) On July 17, 2013, Metabolix, Inc. (the "Company") announced that Johan van Walsem, currently the Company's Vice President of Product Development and Manufacturing, will be promoted to the newly created position of Chief Operating Officer, effective as of July 22, 2013.

Mr. van Walsem has served as the Company's Vice President of Manufacturing and Product Development since early 2012. He returned to Metabolix in August 2009 as Vice President of Strategy and Commercial Development, following a16 month period as Senior Vice President, R&D and Bioprocessing at Joule Biotechnologies, a clean technology start-up company. Previously, Mr. van Walsem served as Metabolix's Vice President of Manufacturing, Development and Operations from October 2003 until April 2008, and was Director of Manufacturing and Development from September 2001 to October 2003.

In connection with Mr. van Walsem's promotion, the Company agreed to increase his base salary to $295,000 per year and to grant him a stock option under the Metabolix, Inc. 2006 Stock Option and Incentive Plan for the purchase of 100,000 shares of common stock of the Company at an exercise price equal to the Fair Market Value (as defined in the Plan) of the Company's common stock on the date of grant, vesting in 16 equal quarterly installments over a period of four years from the date of commencement of his new role.

Item 7.01. Regulation FD Disclosure.

On July 17, 2013, the Company issued a press release announcing Mr. van Walsem's promotion to Chief Operating Officer. The full text of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information set forth in this Item 7.01 and Exhibit 99.1 attached hereto is intended to be furnished and shall not be deemed "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

99.1 Press Release dated July 17, 2013

  Add MBLX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for MBLX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.